Short answer: yes, if (and only if) the compounded product contains the same dose of the same molecule with the same purity.

Introduction Compounded GLP-1 medications are legal when prepared by a state-licensed pharmacy operating under FDA Section 503A or 503B rules, and prescribed by a…

Irisin first appeared in 2012 in a Nature paper by Boström et al. from the Spiegelman lab at Harvard.

The ipamorelin plus GLP-1 combination is one of the more discussed peptide stacks in weight management circles. The pitch is consistent.

Introduction Ipamorelin appears relatively safe in the small set of human studies available, with no signal of cortisol or prolactin elevation and only mild…

Ipamorelin has a more substantial pharmaceutical research history than most peptides in the wellness category.

Ipamorelin works by binding the growth hormone secretagogue receptor type 1a (GHS-R1a), commonly called the ghrelin receptor.

Introduction Ipamorelin dosing in adult off-label use has converged on a few standard protocols across 503A compounding pharmacies and peptide-prescribing clinical practices. The most…

Ipamorelin is a synthetic pentapeptide (five amino acids) developed in the late 1990s as a selective growth hormone secretagogue.